Abstract
While the advances in #revascularization therapy have drastically
decreased the mortality following ST elevation #myocardial infarction (STEMI), the number of patients who develops #heart failure (HF)
following the reperfusion therapy continues to rise. More than 30% of
the patients who survive STEMI develop HF long term [1]. In addition,
patients with a history of acute myocardial infarction (AMI) and left
ventricular (LV) dysfunction have a markedly increased 6 months
mortality of greater than 10% [2] Thus, there is an urgent unmet
clinical need to clarify the mechanisms of SCD and HF post-MI and
develop a #robust biomarker to identify the high-risk patients. The
importance of differentiating the peri- infarct region (PIR) from the
adjacent non-viable infarct core (IC) has been noted recently as it
could independently determine the occurrence of major adverse clinical
events [3,4]. The PIR consisting of heterogeneous tissue components
represents the nexus for active remodeling or repair characterized by
extracellular matrix formation, #angiogenesis, oxidative stress,
mitochondrial energetics, apoptosis and inflammation [5,6]. We here
review the non-invasive MRI approaches to characterize PIR.
For more articles on BJSTR Journal please click on https://biomedres.us/
For more Biomedical Science Articles on BJSTR
T1 Mapping for Quantifying Myocardial Viability in the Peri-Infarct Regions by Phillip C Yang in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.